Eye monitoring and pressurization systems
Assemblies and methods for modifying an intraocular pressure of a patient's one or both eyes are disclosed. The assemblies and methods can be used to treat, inhibit, or prevent ocular conditions such as glaucoma, high intraocular pressure, optic disc edema, idiopathic intracranial hypertension, zero-gravity induced papilledema, and other optic pressure related conditions. An assembly can include a goggle including at least one cavity, a pump in fluid communication with the at least one cavity, and a control mechanism. The control mechanism can be operatively coupled to the pump and can maintain a target pressure or target pressure range in the at least one cavity, which, when the assembly is worn by a patient, is the area between a patient's eye(s) and wall surfaces of the goggle. Controlling the pressure over the outer surfaces of the patient's eye(s) can drive a desired change in the intraocular pressure of the eye(s).
1. A system to treat a patient eye comprising:
a goggle, sized and shaped to fit over the patient eye, configured to define a cavity between the goggle and the patient eye;
a cavity pressure sensor, configured to sense an indication of cavity pressure in the cavity; and
a control circuit configured to receive the indication of cavity pressure and at least one of an indication of intraocular pressure (IOP) level in the patient eye or an indication of cerebrospinal fluid pressure (CSFP) level in the patient,
wherein the control circuit is configured to adjust a pressure source to generate non-ambient pressure in the cavity based at least in part on one of the received indications of IOP level or CSFP level to adjust the indication of IOP level in the patient eye toward a target IOP level.
2. The system of claim 1 ; further comprising a biosensor configured to sense at least one of the indication of IOP level or the indication of CSFP level.
3. The system of claim 2 , wherein the biosensor includes the biosensor configured to sense IOP level.
4. The system of claim 2 , wherein the biosensor includes the biosensor configured to sense the indication of CSFP level.
5. The system of claim 1 ; further comprising a pressure source, in fluidic communication with the cavity, configured to generate non-ambient pressure in the cavity to adjust the indication of cavity pressure sensed by the cavity pressure sensor.
6. The system of claim 5 , wherein the pressure source is configured to generate non-ambient pressure in the cavity greater than ambient pressure surrounding the cavity.
7. The system of claim 5 , wherein the pressure source is configured to generate non-ambient pressure in the cavity less than ambient pressure surrounding the cavity.
8. The system of claim 5 , wherein the control circuit is configured to adjust the pressure source to generate non-ambient pressure in the cavity to equalize an indication of-translaminar pressure (TLP) level associated with the patient eye, wherein equalizing the indication of TLP level includes reducing the indication of TLP level from a first TLP level to a lower second TLP level.
9. The system of claim 5 , wherein the control circuit is configured to adjust the pressure source to generate non-ambient pressure in the cavity to enhance axonal transport in the optic nerve of the patient eye.
10. The system of claim 5 , wherein the control circuit is configured to adjust the pressure source to generate non-ambient pressure in the cavity to help inhibit, treat, or prevent glaucoma or progression of glaucoma in the patient eye.
11. The system of claim 5 , wherein the control circuit is configured to adjust the pressure source to generate non-ambient pressure in the cavity sufficient to achieve an IOP level in a range of about 10 mmHg to about 21 mmHg in the patient eye.
12. A method of using a system to treat a patient eye, the system comprising a goggle, sized and shaped to fit over the patient eye and configured to define a cavity between the goggle and the patient eye, a cavity pressure sensor configured to sense an indication of cavity pressure in the cavity, and a control circuit configured to receive the indication of cavity pressure and at least one of an indication of intraocular pressure (IOP) level in the patient eye or an indication of cerebrospinal fluid pressure (CSFP) level in the patient, wherein the control circuitry is configured to adjust a pressure source to generate non-ambient pressure in the cavity based at least in part on one of the received indications of IOP level or CSFP level to adjust the indication of IOP level in the patient eye toward a target IOP level, the method comprising:
receiving the indication of cavity pressure and at least one of an indication of IOP level or an indication of CSFP level with the control circuit; and
adjusting the pressure source to generate non-ambient pressure in the cavity based at least in part on one of the received indications of IOP level or CSFP level to adjust the indication of IOP level in the patient eye toward a target IOP level.
13. The method of claim 12 , wherein receiving at least one of the indication of IOP level or the indication of CSFP level includes receiving the indication of IOP level.
14. The method of claim 12 , wherein receiving at least one of the indication of IOP level or the indication of CSFP level includes receiving the indication of CSFP level.
15. The method of claim 12 , wherein adjusting the pressure source includes adjusting the pressure source to equalize an indication of translaminar pressure (TLP) level associated with the patient eye, wherein equalizing the indication of TIT level includes reducing the indication of TLP level from a first TLP level to a lower second TLP level.
16. The method of claim 12 , wherein adjusting the pressure source includes adjusting the pressure source toward a target cavity pressure level to enhance axonal transport in the optic nerve of the eye.
17. The method of claim 12 , wherein adjusting the pressure source includes adjusting the pressure source toward a target cavity pressure to inhibit, treat, or prevent glaucoma or the progression of glaucoma in the patient eye.
18. The method of claim 12 , wherein adjusting the pressure source includes adjusting the pressure source to achieve an IOP level in a range of about 10 mmHg to about 21 mmHg in the patient eye.